SEC Company Response from GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) (GALT) — Jun 11, 2009
GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)
Date: June 11, 2009 · CIK: 0001133416 · Accession: 0001193125-09-129416
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-150898
Letter
United States Securities and Exchange Commission Division of Corporation Finance Attention: Ms. Jennifer Riegel Re: Pro-Pharmaceuticals, Inc. Post-Effective Amendment No.2 on Form S-1 Filed June 11, 2009, File No. 333-150898
Dear Ms. Riegel:
Pro-Pharmaceuticals, Inc. (the “company”) hereby requests acceleration of the effective time of the above-referenced registration statement to Monday, June 15, 2009, at 12:00 noon, or as soon thereafter as is possible.
On behalf of the company I hereby acknowledge that:
(1) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
(2) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(3) the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Respectfully submitted,
PRO-PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Letter Pro-Pharmaceuticals, Inc. 7 Wells Avenue Newton, Massachusetts 02459 (617) 559-0033 June 11, 2009 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington DC 20549 Mail Stop 4720 Attention: Ms. Jennifer Riegel Re: Pro-Pharmaceuticals, Inc. Post-Effective Amendment No.2 on Form S-1 Filed June 11, 2009, File No. 333-150898 Dear Ms. Riegel: Pro-Pharmaceuticals, Inc. (the “company”) hereby requests acceleration of the effective time of the above-referenced registration statement to Monday, June 15, 2009, at 12:00 noon, or as soon thereafter as is possible. On behalf of the company I hereby acknowledge that: (1) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (2) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (3) the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Respectfully submitted, PRO-PHARMACEUTICALS, INC. By: /s/ Anthony D. Squeglia Anthony D. Squeglia Chief Financial Officer